Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Insights and Forecast to 2028
Table of Contents1 Study Coverage
1.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Pediatric Hepatitis B (CHO) Vaccine
1.2.3 Adult Hepatitis B (CHO) Vaccine
1.3 Market by Application
1.3.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region
2.4.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by Region (2023-2028)
2.5 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region
2.5.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region (2017-2022)
2.5.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Manufacturers
3.1.1 Global Top Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine in 2021
3.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Manufacturers
3.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue in 2021
3.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type
4.1.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type
4.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Type
4.3.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Type (2017-2022)
4.3.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application
5.1.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application
5.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Application
5.3.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Application (2017-2022)
5.3.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Type
6.1.1 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2017-2028)
6.1.2 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type (2017-2028)
6.2 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Application
6.2.1 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2017-2028)
6.2.2 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2017-2028)
6.3 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country
6.3.1 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2017-2028)
6.3.2 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Type
7.1.1 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2017-2028)
7.1.2 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type (2017-2028)
7.2 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Application
7.2.1 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2017-2028)
7.2.2 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2017-2028)
7.3 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country
7.3.1 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2017-2028)
7.3.2 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Type
8.1.1 Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Application
8.2.1 Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Region
8.3.1 Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Type
9.1.1 Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type (2017-2028)
9.2 Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Application
9.2.1 Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2017-2028)
9.3 Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country
9.3.1 Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Type
10.1.1 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Application
10.2.1 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Country
10.3.1 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Merck & Co., Inc.
11.1.1 Merck & Co., Inc. Corporation Information
11.1.2 Merck & Co., Inc. Overview
11.1.3 Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck & Co., Inc. Recent Developments
11.2 GlaxoSmithKline Plc
11.2.1 GlaxoSmithKline Plc Corporation Information
11.2.2 GlaxoSmithKline Plc Overview
11.2.3 GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GlaxoSmithKline Plc Recent Developments
11.3 Pfizer Inc.
11.3.1 Pfizer Inc. Corporation Information
11.3.2 Pfizer Inc. Overview
11.3.3 Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pfizer Inc. Recent Developments
11.4 Sanofi Pasteur
11.4.1 Sanofi Pasteur Corporation Information
11.4.2 Sanofi Pasteur Overview
11.4.3 Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sanofi Pasteur Recent Developments
11.5 CSL Limited
11.5.1 CSL Limited Corporation Information
11.5.2 CSL Limited Overview
11.5.3 CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 CSL Limited Recent Developments
11.6 Emergent Biosolutions
11.6.1 Emergent Biosolutions Corporation Information
11.6.2 Emergent Biosolutions Overview
11.6.3 Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Emergent Biosolutions Recent Developments
11.7 Serum Institute of India
11.7.1 Serum Institute of India Corporation Information
11.7.2 Serum Institute of India Overview
11.7.3 Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Serum Institute of India Recent Developments
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Corporation Information
11.8.2 Johnson & Johnson Overview
11.8.3 Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Johnson & Johnson Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Chain Analysis
12.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Mode & Process
12.4 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Marketing
12.4.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Channels
12.4.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Distributors
12.5 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Trends
13.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Drivers
13.3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Challenges
13.4 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Restraints
14 Key Findings in The Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of TablesTable 1. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Pediatric Hepatitis B (CHO) Vaccine
Table 3. Major Manufacturers of Adult Hepatitis B (CHO) Vaccine
Table 4. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region (2017-2022) & (K Doses)
Table 7. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Region (2017-2022)
Table 8. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region (2023-2028) & (K Doses)
Table 9. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Region (2023-2028)
Table 10. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Region (2017-2022)
Table 12. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Region (2023-2028)
Table 14. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Manufacturers (2017-2022) & (K Doses)
Table 15. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Share by Manufacturers (2017-2022)
Table 16. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Share by Manufacturers (2017-2022)
Table 18. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Manufacturers (2017-2022) &(USD/Dose)
Table 19. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine as of 2021)
Table 21. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Offered
Table 23. Date of Manufacturers Enter into Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2017-2022) & (K Doses)
Table 26. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2023-2028) & (K Doses)
Table 27. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Share by Type (2017-2022)
Table 28. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Share by Type (2023-2028)
Table 29. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Share by Type (2017-2022)
Table 32. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Share by Type (2023-2028)
Table 33. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Type (2017-2022) & (USD/Dose)
Table 34. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price Forecast by Type (2023-2028) & (USD/Dose)
Table 35. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2017-2022) & (K Doses)
Table 36. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2023-2028) & (K Doses)
Table 37. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Share by Application (2017-2022)
Table 38. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Share by Application (2023-2028)
Table 39. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Share by Application (2017-2022)
Table 42. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Share by Application (2023-2028)
Table 43. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Application (2017-2022) & (USD/Dose)
Table 44. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price Forecast by Application (2023-2028) & (USD/Dose)
Table 45. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2017-2022) & (K Doses)
Table 46. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2023-2028) & (K Doses)
Table 47. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2017-2022) & (K Doses)
Table 50. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2023-2028) & (K Doses)
Table 51. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2017-2022) & (K Doses)
Table 54. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2023-2028) & (K Doses)
Table 55. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2017-2022) & (K Doses)
Table 58. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2023-2028) & (K Doses)
Table 59. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2017-2022) & (K Doses)
Table 62. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2023-2028) & (K Doses)
Table 63. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2017-2022) & (K Doses)
Table 66. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2023-2028) & (K Doses)
Table 67. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2017-2022) & (K Doses)
Table 70. Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2023-2028) & (K Doses)
Table 71. Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2017-2022) & (K Doses)
Table 74. Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2023-2028) & (K Doses)
Table 75. Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region (2017-2022) & (K Doses)
Table 78. Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region (2023-2028) & (K Doses)
Table 79. Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2017-2022) & (K Doses)
Table 82. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2023-2028) & (K Doses)
Table 83. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2017-2022) & (K Doses)
Table 86. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2023-2028) & (K Doses)
Table 87. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2017-2022) & (K Doses)
Table 90. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2023-2028) & (K Doses)
Table 91. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2017-2022) & (K Doses)
Table 94. Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2023-2028) & (K Doses)
Table 95. Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2017-2022) & (K Doses)
Table 98. Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2023-2028) & (K Doses)
Table 99. Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2017-2022) & (K Doses)
Table 102. Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2023-2028) & (K Doses)
Table 103. Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 105. Merck & Co., Inc. Corporation Information
Table 106. Merck & Co., Inc. Description and Major Businesses
Table 107. Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 108. Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Merck & Co., Inc. Recent Developments
Table 110. GlaxoSmithKline Plc Corporation Information
Table 111. GlaxoSmithKline Plc Description and Major Businesses
Table 112. GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 113. GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. GlaxoSmithKline Plc Recent Developments
Table 115. Pfizer Inc. Corporation Information
Table 116. Pfizer Inc. Description and Major Businesses
Table 117. Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 118. Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Pfizer Inc. Recent Developments
Table 120. Sanofi Pasteur Corporation Information
Table 121. Sanofi Pasteur Description and Major Businesses
Table 122. Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 123. Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Sanofi Pasteur Recent Developments
Table 125. CSL Limited Corporation Information
Table 126. CSL Limited Description and Major Businesses
Table 127. CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 128. CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. CSL Limited Recent Developments
Table 130. Emergent Biosolutions Corporation Information
Table 131. Emergent Biosolutions Description and Major Businesses
Table 132. Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 133. Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Spe